We are global leader in the laboratory diagnostics market, specializing in the immunodiagnostics and molecular diagnostics segments.
For over 50 years we have been dealing with diagnostics to help physicians and patients make better decisions in the most important moments.
Diagnosis is, in fact, the first step to become aware of a person’s state of health: this is why our tests can make the difference. Their precision and reliability allow the early diagnosis of different diseases for millions of people, who will be able to undertake the appropriate clinical pathway.
We are a multinational company operating across 5 continents. Our headquarters are in Saluggia Italy, and the Group production platform involves 6 manufacturing plants around the world.
Our research and development centers are based in Italy, USA and Germany
LIAISON® XL: high throughput immunoassay analyzer
LIAISON® MDX: molecular analyzer
Study on the immune response of individuals post natural infection with SARS-CoV-2
Reference: Bonelli et al. Evaluation of the automated LIAISON ® SARS-CoV-2 TrimericS IgG assay for the detection of circulating antibodies. Clin Chem Lab Med. 2021 Mar 12.
Other DiaSorin-sponsored SARS-CoV-2 Educational Sessions
Putting the Cart Before the Horse: SARS-CoV-2 Antibody Tests
Speaker: David G Grenache, PhD, MT(ASCP), D(ABCC) Chief Scientific Officer for TriCore Reference Laboratories
Coronavirus Disease 2019 (COVID-19): Role of Serologic Testing in Diagnosis and Assessment of Viral Immunity
Speaker: David M Engman, MD, PhD Chairman Emeritus of Pathology, Cedars Sinai Medical Center- Clinical Professor of Pathology, UCLA – Adjunct Professor of Pathology, Northwestern University.
Role of Cov-2 Serology in a vaccinated world
Speaker: David M. Engman, MD, PhD, Chairman Emeritus of Pathology, Cedars Sinai Medical Center – Clinical Professor of Pathology, UCLA – Adjunct Professor of Pathology, Northwestern University